Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

BIO 2015 Provides Local Shoe Shiner with School Supplies for Kids in Need

AbbVie3

For the past decade, William Green, a center city shoe shiner, hosts a Children’s Cookout and Day of Fun in late August for poverty stricken children in Philadelphia. In addition to providing a day of safe fun for local children, “Big Will’s” cookout provides an opportunity to supply book bags and school supplies to more than 500 needy students throughout the city. Today, the 2015 BIO International Convention provided “Big Will” with over 500 hundred Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Scientific American WorldView Super Session and the Future of Innovation

FullSizeRender1

The final Super Session of the 2015 BIO International Convention today featured a panel of international luminaries who offered their perspective on the future of innovation. Moderated by television and radio journalist, David Brancaccio, host of Marketplace Morning Report, the panelists provided a fresh perspectives on international life science development and the ways disruptive technologies are changing how we do business and experience the world around us. On the panel: Lee Hood, President of Institute Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Sen Menendez Asks SEC to Investigate IPR Abuses

Securities and Exchange Commission

New Jersey Senator Bob Menendez has asked the Securities and Exchange Commissioner (SEC) to investigate a new investment scheme designed to manipulate the stock prices of companies engaged in research and development of innovative medical therapies, to determine if the practice is illegal. As reported in this Bloomberg Business article, certain investment firms are shorting the stocks of patent-dependent life sciences companies and then using new patent litigation procedures to challenge their patents and drive Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

2015 BIO Legislative Day Fly-In

BIO_FLY-IN

More than 300 biotechnology industry representatives from over 40 states, representing hundreds of thousands of American workers, participated in hundreds of meetings with Members of the House and Senate during the BIO Legislative Day Fly-In. Participants discussed issues critical to the biotechnology industry including, drug development, discovery and delivery reforms, targeting abuses of the U.S. patent system while protecting innovation, providing adequate reimbursement for vital therapies under Medicare, FDA funding, tax policy, support for science-based Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Virginia Bio Announces Conference Featuring Gov. McAuliffe

vabio

Virginia Bio has announced that its bioscience centered THRiVE 2015 Conference will feature a Governor’s Forum on Bio and Big Data/Analytics. “We are proud to present this opportunity for direct interaction with some of the most influential thought leaders in the bioscience industry.” Jeffrey M. Gallagher, CEO, Virginia Bio Click Here to Register Virginia’s own Governor Terry McAuliffe will be on hand, as will bioscience leaders from across the state and beyond – including companies, universities, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,